AQEMIA raises €60M to boost its AI-powered drug discovery platform and pipeline
AQEMIA, a tech-enabled drug discovery company that uses generative AI and deep physics to find new drugs, has secured an additional €30 million investment, bringing its Series A round to €60 million. The round was led by Wendel Growth and supported by existing investors Bpifrance Large Venture, Eurazeo and Elaia. The funding comes after AQEMIA’s…